Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer

被引:20
作者
Geisler, JP
Schraith, DF
Manahan, KJ
Sorosky, JI
机构
[1] Univ Iowa, Hosp & Clin, Dept Obstet & Gynecol, Div Gynecol Oncol,Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[2] Univ Iowa, Hosp & Clin, Holden Comprehens Canc Ctr, Dept Pathol, Iowa City, IA 52242 USA
关键词
gemcitabine; ovarian neoplasm; vasculitis; peritoneal neoplasm; necrotizing enterocolitis;
D O I
10.1016/j.ygyno.2003.10.050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We present two patients who developed necrotizing enterocolitis following their first cycle of chemotherapy for epithelial ovarian/peritoneal cancer. After optimal cytoreductive surgery, both women received gemcitabine as part of a chemotherapy protocol. One patient developed necrotizing enterocolitis, 1 day after chemotherapy and the other 8 days after chemotherapy. The first patient succumbed to the enterocolitis despite aggressive supportive care. The second patient succumbed despite both aggressive supportive care and surgical intervention. Pathologic review for both patients revealed a drug induced vasculitis causing necrotizing enterocolitis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:705 / 707
页数:3
相关论文
共 16 条
  • [1] Banach MJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P726
  • [2] Calabrese Leonard H., 1996, Current Opinion in Rheumatology, V8, P34, DOI 10.1097/00002281-199601000-00006
  • [3] CHRISTMAN K, 1994, CANCER, V73, P5, DOI 10.1002/1097-0142(19940101)73:1<5::AID-CNCR2820730103>3.0.CO
  • [4] 2-#
  • [5] Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer
    D'Agostino, G
    Amant, F
    Berteloot, P
    Scambia, G
    Vergote, I
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 88 (03) : 266 - 269
  • [6] Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies - A Gynecologic Oncology Group study
    Garcia, AA
    Bookman, MA
    Rodriguez-Rodriguez, L
    Mutch, DG
    Look, KY
    [J]. INVESTIGATIONAL NEW DRUGS, 2002, 20 (04) : 383 - 387
  • [7] Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients
    Lund, B
    Hansen, OP
    Neijt, JP
    Theilade, K
    Hansen, M
    [J]. ANTI-CANCER DRUGS, 1995, 6 : 61 - 62
  • [8] Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients
    Nagourney, RA
    Brewer, CA
    Radecki, S
    Kidder, WA
    Sommers, BL
    Evans, SS
    Minor, DR
    DiSaia, PJ
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 88 (01) : 35 - 39
  • [9] PESTALOZZI BC, 1993, CANCER, V71, P1797, DOI 10.1002/1097-0142(19930301)71:5<1797::AID-CNCR2820710514>3.0.CO
  • [10] 2-B